首页> 外国专利> DENDROASPIS NATRIURETIC PEPTIDE

DENDROASPIS NATRIURETIC PEPTIDE

机译:石END钠尿肽

摘要

Disclosed is a method of inhibiting the growth of a cancer cell using Dendroaspis natriuretic peptide (DNP), isolated from the Green Mamba snake venom with similar structure to ANP, with or without four cardiac natriuretic peptides i.e., atrial natriuretic peptide (ANP), vessel dilator, long acting natriuretic peptide (LANP), and kaliuretic peptide. Dose-response curves revealed a significant (p0.0001) decrease in human glioblastoma cells with each ten-fold increase in concentration from 1 μM to 100 μM of four of the cardiac peptide hormones. There was an 75%, 68%, 67%, and 65% elimination within 24 hours of glioblastoma cells secondary to vessel dilator, kaliuretic peptide, ANP, and LANP, respectively (p0.0001) while DNP had no significant effect at 1 μM (2% decrease), and 10 μM (7%), but 100 μM caused a (17%) decrease (p0.05). Three days after treatment with these peptide hormones, the cancer cells began to proliferate again. These same hormones decreased DNA synthesis from 65% to 87% (p0.00001).
机译:本发明公开了一种使用登革蝇钠肽(DNP)抑制癌细胞生长的方法,该肽分离自具有与ANP相似结构的绿曼巴蛇毒,具有或不具有四种心脏钠肽,即心钠素(ANP),血管扩张剂,长效利钠肽(LANP)和利尿肽。剂量反应曲线显示人胶质母细胞瘤细胞显着(p <0.0001)减少,其中四种心脏肽激素的浓度从1μM增加到100μM每增加10倍。胶质母细胞瘤细胞继发于血管扩张剂,利尿肽,ANP和LANP后24小时内分别消除了75%,68%,67%和65%(p <0.0001),而DNP在1μM时无明显作用(减少2%)和10μM(7%),但是100μM导致(17%)减少(p <0.05)。用这些肽激素治疗三天后,癌细胞又开始增殖。这些相同的激素使DNA合成从65%降至87%(p <0.00001)。

著录项

  • 公开/公告号US2008039394A1

    专利类型

  • 公开/公告日2008-02-14

    原文格式PDF

  • 申请/专利权人 DAVID L. VESELY;

    申请/专利号US20070833757

  • 发明设计人 DAVID L. VESELY;

    申请日2007-08-03

  • 分类号A61K38/22;A61K38/02;A61P35;

  • 国家 US

  • 入库时间 2022-08-21 20:13:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号